Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombophilia × Dalteparin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 16 Venous Thrombosis 12 Pulmonary Embolism 11 Neoplasms 10 Thrombosis 4 Thromboembolism 4 Pancreatic Neoplasms 4 Lung Neoplasms 4 Multiple Myeloma 3 Neoplasm Metastasis 2 Lymphoma 2 Hemorrhage 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombophilia 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1

Interventions

enoxaparin sodium 1 Observation 1 Lead 1 Injections 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡